Vertex, which is currently based in Cambridge, MA, says it plans to move its headquarters to the Fan Pier district of Boston in 2013. According to Xconomy Boston’s mayor offered Vertex tax incentives as he attempts to build an ‘innovation district’ in the city. The move is dependant upon Vertex receiving FDA approval for its promising hepatitis C drug telaprevir.

View PDF

single-post.php